Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for severe alopecia areata are unsatisfactory, highlighting the need for better options.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

The new hair loss treatment kit was safe and improved hair growth without any adverse effects.

Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Atopic dermatitis is common in developing countries, but many patients receive poor care due to inconsistent guidelines and lack of resources.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Alopecia areata affects quality of life more in adolescents than adults.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Bariatric surgery can improve some skin issues but may worsen others due to nutritional deficiencies.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

New regenerative treatments for hair loss show promise but need more research for confirmation.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.